top of page

Updated: Jan 12, 2021


On December 27, 2020, the President signed the Trademark Modernization Act of 2020 (“TMA”) into law when he signed the year-end Consolidated Appropriations Act for 2021. The TMA, which will become effective within one year of its signing, introduces several amendments to the Lanham Act to address the issue of false trademark registrations, clarify the standard for obtaining injunctive relief by restoring the presumption of irreparable harm once a trademark violation has been proven, and provide immunity to Administrative Law Judges (ALJ) of the Trademark Trial and Appeal Board (TTAB) against challenges to its independence under the Appointments Clause of the Constitution.


To address the issue of false registrations, i.e., marks that falsely claim to be used in commerce to obtain or maintain a trademark registration, the TMA has introduced several new amendments. For instance, the TMA now codifies the current letter of protest procedures that are designed to allow third parties to submit evidence to contest a trademark application during its examination. Currently, the existing procedures are informal, e.g., it does not specify a timeline in which a letter of protest must reach the trademark examiner nor does it require any filing fees. Under the TMA, the Director of the USPTO will have two months to review a letter of protest’s evidence and will allow it to establish appropriate procedures for the consideration of the evidence and whether to establish any additional filing fees.


Additionally, to address other false registrations, such as “deadwood” trademarks (i.e., marks that remain registered but are not in use in commerce), the TMA introduces new ex parte reexamination and expungement procedures that to allow the USPTO to cancel a registration on the basis of nonuse. Specifically, the ex parte reexamination procedures allow for the cancellation of a mark that has never been used in commerce on or in connection with some or all of the goods or services recited in the registration. Ex Parte expungement procedures allow for cancellation of a mark that has never been used in commerce. These new procedures, however, become unavailable after the targeted registration has passed its fifth anniversary.


For the standard of obtaining injunctive relief, the TMA clarifies that for trademark violations, a rebuttable presumption of irreparable harm exists. Before the Supreme Court’s decision in eBay, Inc. v. MercExchange LLC, 547 U.S. 388 (2006), if trademark owner prevailed in an infringement lawsuit, the owner would be entitled to a presumption that the court would award an injunction against the competitor’s continuing use of a confusingly similar trademark so that consumers would not be misled about the source of a good or service. The Supreme Court decision in this case, however, held that a presumption of irreparable harm could not be applied to its patent infringement case. Given that Lanham Act did not explicitly specify a presumption of irreparable harm for an injunction, a circuit split developed as to whether such presumptions are appropriate in trademark cases. The TMA, however, now abrogates court decisions that have applied eBay to trademark cases and eliminated the presumption of irreparable harm.


Lastly, the TMA seeks to avoid legal challenges to ALJs of the TTAB under the Appointment Clause of the Constitution. Specifically, in Arthrex v. Smith & Nephew, 941 F.3d 1320 (Fed. Cir. 2019) the Federal Circuit held that Patent Trial and Appeal Board (PTAB) judges were not subject to sufficient oversight and supervision by the Director to be considered inferior officers under the Appointments Clause of the Constitution, and thus were unconstitutionally appointed since they had not been nominated by the President and confirmed by the Senate. Although this decision was in reference to the PTAB and not the TTAB, to avoid potential legal challenges to the TTAB’s decisions the TMA provides the Director with additional oversight of TTAB’s decisions. Specifically, it states the “Director may reconsider, and modify or set aside, a decision of the Trademark Trial and Appeal Board under this section.”


Sources:


On September 2, 2020, the Shanghai Third Intermediate Court sentenced nine individuals to up to six years in prison and fines of RMB 90 million (approximately $13 million) for infringing on the Danish toymaker LEGO’s products.


Specifically, the nine individuals were sentenced for distributing toy products significantly similar to LEGO’s products under the brand name LEPIN (乐拼). This group began its operation in 2015 under the company name Shantou Meizhi Model Co., Ltd, where it had purchased LEGO sets, dismantled and studied them, and then recreated them in their own factories for resale. The re-creations were a one-to-one replica of LEGO’s products. Over the years, LEPIN sold approximately over RMB 300 Million worth of these counterfeit toys.


LEGO had sued the creator of LEPIN, Shantou Meizhi Model Co., Ltd, for copyright infringement and unfair competition under China’s Copyright Law in 2017. The Guangzhou Intellectual Property Court sided with LEGO and ordered the company to halt all infringing activity. It also awarded LEGO RMB 4.7 million (approximately $717,000) in damages. On April 23, 2019, Shanghai police seized 603,875 LEPIN toy products worth approximately RMB 31.5 million in a factory leased by one of the nine sentenced.


"We appreciate the continued focus on intellectual property protection and enforcement by the Chinese courts and authorities. It is important for the continued development of a favourable [sic] business environment for all companies operating in China. We will continue to take action against companies that breach our copyrights and seek to mislead our consumers," LEGO Group told the Global Times.

Image from the Global Times

Sources:


Provided by Unified Patents

The Patent Trials Appeals Board (PTAB) of the United States Patent and Trademark Office (USPTO) had requested comments on 10/20/20 to its proposed rule to codify its current discretionary denial policies and practices (i.e., denial of a patent review for reasons other than the case’s merits). This proposed rule (Docket Number PTO-C-2020-0055) has received 843 comments as of its Thursday deadline of 12/03/20.


The Director of the USPTO, under current law, is not obligated to grant Inter Partes Review (IPR) or Post Grant Review (PGR) unless the petitioner demonstrates “a reasonable likelihood” of prevailing on the merits. There have been cases, however, where patent holder has requested an IPR or PGR to be denied for reasons other than the merit of the petitioner’s claim (e.g., the existence of parallel petitions, proceedings in other tribunals, etc.) and the PTAB has used its discretion to deny the review.


The PTAB use of discretionary denials has increased significantly over the past few years. These discretionary denials of IPR and PGR has had a compounding affect as several of the PTAB decisions have been designated as precedential, i.e., decision have a binding effect on subsequent reviews. The PTAB states that it has done so in an effort to increase consistency, efficiency, and fairness in the review process. Principally, there have been three situations in which the PTAB has found review not necessary:

  • serial petitions;

  • parallel petitions; and

  • proceedings in other tribunals.

An example of serial petitions is found in PTAB’s precedential General Plastic Co. decision. Specifically, the PTAB “recognize[d] the potential for abuse of the review process by repeated attacks on patents” by the same party. This decision set forth seven nonexclusive factors that the PTAB will consider when deciding whether to institute an additional “follow-on” petition filed by the same party. The PTAB in its Valve decisions further extended this restriction on serial petitions to include co-defendants that coordinate serial attacks against the same patent.


For parallel petitions, the PTAB has denied review in cases where the same issue is being petitioned in multiple forums (e.g., district court) at the same time. In the PTAB’s view, one petition should be sufficient to resolve the issue of patentability in most instances.


For proceedings in other tribunals, the PTAB has denied review in situations where there is already an ongoing case in another forum that may analyze the issue and render a decision before the PTAB would be able to issue its final decision. The PTAB established a six-factor test in its precedential Fintiv and NHK Spring decisions as to when denying a review in such cases is appropriate.


Several comments have been filed for and against this new proposed rule. U.S.A. Senator Christopher A. Coons of Delaware and Mazie K. Hirono of Hawaii, have stated that the changes enacted by the USPTO have helped repair a system that was "tipping the scales away from the inventors who helped build America and toward infringers who steal the fruits of their labor." Inventor Josh Malone, a vocal critic of the PTAB, said "it is crucial that the office establish procedures on the use of discretion that account for the unique harms to small practicing entities." He said patent challenges often involve powerful corporations "[weaponizing] the PTAB to crush a smaller competitor with superior technology."


Others have come out against these new rules. Specifically, at least five comments warned that codifying rules about discretionary denials will have a harmful effect on the cost of prescription drugs. Public Citizen, Consumer Action and the Coalition Against Patent Abuse each said that denying petitions that otherwise have merit will delay how long it takes for generic drugs to get on the market.


Sources:

  • Docket Number PTO-C-2020-0055

  • Unified Patents

  • Law360

  • Valve Corp. v. Elec. Scripting Prods., Inc., IPR2019-00062, 2019 WL 1490575 (PTAB Apr. 2, 2019).

  • Valve Corp. v. Elec. Scripting Prods., Inc., 2019 WL 1965688 (PTAB May 1, 2019).

  • Apple Inc. v. Fintiv, Inc., IPR2020-00019, 2020 WL 2126495 (PTAB Mar. 20, 2020).

  • NHK Spring Co., Ltd. v. Intri-Plex Techs., Inc., IPR2018-00752, 2018 WL 4373643 (PTAB Sept. 12, 2018)



Blog: Blog2

©2020 by Secondary Meaning News™

bottom of page